Dear Sir, Please find Outcome of the Board Meeting held on 30 May, 2026 of Omkar Pharmachem Limited
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Omkar Pharmachem Ltd reported audited financial results for the year ended March 31, 2026. The company showed zero revenue from operations with only other operating income of Rs. 46.50 lakh (down from Rs. 54 lakh in prior year). Net profit declined to Rs. 12.18 lakh from Rs. 20.09 lakh in the previous year, representing a 39.4% drop in PAT. However, total comprehensive income surged to Rs. 2720.61 lakh due to a large other comprehensive income of Rs. 2708.43 lakh, likely from fair value changes in investments which increased significantly to Rs. 3638.43 lakh from Rs. 930 lakh. The auditor issued an unmodified opinion with no going concern issues raised.
The company faces revenue decline with zero sales income, relying entirely on other operating income. The PAT decline of ~39% is concerning though the large OCI boost inflates total comprehensive income. Shareholders should monitor the sustainability of other income sources given the absence of core operational revenue.